Page 1

♥ CVSHealth KEY FINANCIAL DATA WOONSOCKET , RHODE ISLAND , November 3 , 2021 CVS Health Corporation ( NYSE : CVS ) today announced operating results for the three months ended September 30 , 2021 . In millions , except per share amounts Total revenues Operating income Adjusted operating income Diluted earnings per share Adjusted EPS ( 2 ) ( 1 ) CEO COMMENTARY Three Months Ended September 30 , 2021 2020 Change $ 73,794 $ 67,056 $ 6,738 3,061 3,249 ( 188 ) 4,073 3,622 451 0.93 $ 0.27 1.66 $ 0.31 $ $ 1.20 $ 1.97 $ " We outperformed expectations once again and continue to lead the way in changing how , when and where care is delivered for millions of Americans , " said CVS Health President and CEO Karen S. Lynch . " Our services are responsive to evolving consumer needs , from administering millions of COVID - 19 tests and vaccines to offering primary care accessible from virtually anywhere , and our touchpoints allow for unmatched impact . " 1 CVS HEALTH REPORTS STRONG THIRD QUARTER RESULTS THIRD QUARTER HIGHLIGHTS Total revenues increased to $ 73.8 billion , up 10.0 % compared to prior year GAAP diluted EPS of $ 1.20 , up 29.0 % compared to prior year Adjusted EPS of $ 1.97 , up 18.7 % compared to prior year YEAR - TO - DATE HIGHLIGHTS ● Exhibit 99.1 Total revenues increased to $ 215.5 billion , up 8.2 % compared to prior year GAAP diluted EPS of $ 4.98 and Adjusted EPS of $ 6.43 Generated cash flow from operations of $ 14.3 billion Net repayments of long - term debt of $ 6.5 billion 2021 FULL YEAR GUIDANCE Revised GAAP diluted EPS guidance range to $ 6.13 to $ 6.23 from $ 6.35 to $ 6.45 Raised Adjusted EPS guidance range to $ 7.90 to $ 8.00 from $ 7.70 to $ 7.80 Raised cash flow from operations guidance range to $ 13.0 billion to $ 13.5 billion from $ 12.5 billion to $ 13.0 billion The Company presents both GAAP and non - GAAP financial measures in this press release to assist in the comparison of the Company's past financial performance with its current financial performance . See " Non - GAAP Financial Information " beginning on page 11 and endnotes beginning on page 22 for explanations of non - GAAP financial measures presented in this press release . See pages 13 , 14 and 21 for reconciliations of each non - GAAP financial measure used in this release to the most directly comparable GAAP financial measure . Investor Contact : Susie Lisa , CFA | Senior Vice President Investor Relations | ( 401 ) 770-4050 Media Contact : T.J. Crawford | Vice President External Affairs | ( 212 ) 457-0583